US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

LandBridge Co. LLC

85.69

-0.1491-0.17%

Volume:73.87K

Turnover:6.34M

Market Cap:6.61B

PE:75.83

High:86.65

Open:85.61

Low:85.12

Close:85.84

52wk High:91.69

52wk Low:43.75

Shares:77.09M

Float Shares:27.69M

Volume Ratio:3.07

T/O Rate:0.27%

Dividend:0.44

Dividend Rate:0.51%

EPS(TTM):1.13

EPS(LYR):0.9358

ROE:11.52%

ROA:7.07%

PB:18.58

PE(LYR):91.57

Loading ...

Overview Company News Filings

LB Pharmaceuticals Initiated at Buy by Craig-Hallum

Lixte Biotech Holdings (NASDAQ: LIXT) Advances Precision Oncology Strategy with LB-100, Expands Clinical and Strategic Partnerships

LB Pharmaceuticals initiated with a Buy at Craig-Hallum

LB Pharmaceuticals Announces Presentation at 25th Annual Needham Virtual Healthcare Conference

LB Pharmaceuticals files to sell 4.78M shares of common stock for holders

LandBridge signs lease development deal with PowerBridge for 2 GW West Texas data center campus

Landbridge Announces Agreement With Powerbridge for the Development of a 2 Gw Powered Data Center Campus

THOMSON REUTERS

LIXTE Biotechnology (NASDAQ: LIXT) Strengthens Oncology Pipeline Through Expanded LB-100 Clinical Trials

LB Aluminium Malaysia 3rd-Quarter 2026 Earnings Summary Table

Lixte Biotech (NASDAQ: LIXT) Advances Precision Oncology with LB-100, Strengthens Position Through Liora Technologies Partnership

LB Pharmaceuticals Q4 EPS $(0.45) Beats $(0.63) Estimate.

Benzinga Earnings

LB Pharmaceuticals reports Q4 EPS (45c), consensus (32c)

Press Release: LB Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

LB Pharmaceuticals Initiates Pivotal Phase 3 Trial (NOVA-2) for LB-102 in Patients with Schizophrenia

VisionWave Secures Exclusive Pathway to Offshore Energy Blocks LB-4 & LB-5 In Liberia

Vaxcyte Completes Enrollment of OPUS-1 and OPUS-2 Phase 3 Trials Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults

Analysts Offer Insights on Energy Companies: Precision Drilling (PDS) and LandBridge Company LLC Class A (LB)

Analysts Offer Insights on Energy Companies: Phillips 66 (PSX) and LandBridge Company LLC Class A (LB)

LandBridge Company LLC Class A (LB) Receives a Rating Update from a Top Analyst

CervoMed Highlights RewinD-LB Phase 2b Biomarker-Driven Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/LB/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LB\",,,,,undefined,":{"symbol":"LB","market":"US","secType":"STK","nameCN":"LandBridge Co. LLC","latestPrice":85.6909,"timestamp":1788358428456,"preClose":85.84,"halted":0,"volume":73873,"delay":0,"changeRate":-0.0017369524697111395,"floatShares":27691700,"shares":77085400,"eps":1.13,"marketStatus":"Trading","change":-0.1491,"latestTime":"09-02 10:14:10 EDT","open":85.605,"high":86.65,"low":85.12,"amount":6337511.185948,"amplitude":0.017824,"askPrice":85.92,"askSize":1,"bidPrice":85.05,"bidSize":100,"shortable":3,"etf":0,"ttmEps":1.13,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788379200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1719547200000,"exchange":"NYSE","adjPreClose":85.84,"dividendRate":0.005135,"postHourTrading":{"tag":"盘后","latestPrice":85.84,"preClose":85.84,"latestTime":"19:30 EDT","volume":1256,"amount":107797.9479,"timestamp":1788305406444,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":3.067324,"impliedVol":0.5082,"impliedVolPercentile":0.0952},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LB\",,,,,undefined,":{"symbol":"LB","floatShares":27691700,"roa":"7.07%","roe":"11.52%","lyrEps":0.935797,"volumeRatio":3.067324,"shares":77085400,"dividePrice":0.44,"high":86.65,"amplitude":0.017824,"preClose":85.84,"low":85.12,"week52Low":43.75,"pbRate":"18.58","psRate":"29.30","week52High":91.69,"institutionHeld":0.5647,"latestPrice":85.6909,"committee":0.980198,"eps":1.13,"divideRate":0.005135,"volume":73873,"delay":0,"ttmEps":1.13,"open":85.605,"prevYearClose":48.99,"prevWeekClose":86.94,"prevMonthClose":87.58,"prevQuarterClose":79.24,"fiveDayClose":88.59,"twentyDayClose":75.63,"sixtyDayClose":69.66,"dividendPayoutRate":0.3379160380020376,"dividendFrequency":"Q","dividendGrowthYears":1,"dividendGrowthRate":3.0000000000000004,"fiveYearAvgDividendRate":0.00474923066616075},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LB\",params:#limit:5,,,undefined,":[{"date":"2026-08-27","symbol":"LB","amount":0.12,"announcedDate":"2026-08-05","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-27","defaultRemindTime":1787837400000,"name":"LandBridge Co. LLC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-10","payableDate":"2026-08-27","currency":"USD","dateTimestamp":1787803200000,"payDate":"2026-09-10"},{"market":"US","date":"2026-08-05","symbol":"LB","fiscalQuarterEnding":"2026/06","expectedEps":0.37,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"post","actualEps":0.4},{"date":"2026-06-04","symbol":"LB","amount":0.12,"announcedDate":"2026-05-06","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-04","defaultRemindTime":1780579800000,"name":"LandBridge Co. LLC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-04","currency":"USD","dateTimestamp":1780545600000,"payDate":"2026-06-18"},{"date":"2026-05-06","symbol":"LB","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2026/03","expectedEps":0.81,"defaultRemindTime":1778097600000,"name":null,"time":"Post-Mkt","dateTimestamp":1778040000000,"actualEps":null},{"date":"2026-03-05","symbol":"LB","amount":0.12,"announcedDate":"2026-02-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-05","defaultRemindTime":1772721000000,"name":"LandBridge Co. LLC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-19","payableDate":"2026-03-05","currency":"USD","dateTimestamp":1772686800000,"payDate":"2026-03-19"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LB\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-05","recordDate":"2024-12-05","paymentDate":"2024-12-19","value":0.1,"currency":"USD"},{"executeDate":"2025-03-06","recordDate":"2025-03-06","paymentDate":"2025-03-20","value":0.1,"currency":"USD"},{"executeDate":"2025-06-05","recordDate":"2025-06-05","paymentDate":"2025-06-19","value":0.1,"currency":"USD"},{"executeDate":"2025-09-04","recordDate":"2025-09-04","paymentDate":"2025-09-18","value":0.1,"currency":"USD"},{"executeDate":"2025-12-04","recordDate":"2025-12-04","paymentDate":"2025-12-18","value":0.1,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.625,"hold":0.375,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.625,"analysts":8,"updateTime":1763092800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LB","date":"2026-08-31","current":75.964602,"percent":0.572779,"low":-38.681715,"twenty":20.409306,"median":63.430314,"eighty":292.888933,"high":2462.509906,"avg":311.674423,"sd":619.314077,"marketCap":2469485838},"quantilePoints":[{"date":"2024-06-28","current":9.410815,"twenty":-11.330837,"median":5.432312,"eighty":12.760309,"marketCap":594500000},{"date":"2024-07-05","current":6.620022,"twenty":-11.330837,"median":5.416906,"eighty":12.760309,"marketCap":418200000},{"date":"2024-07-12","current":8.247443,"twenty":-11.330837,"median":5.416906,"eighty":12.760309,"marketCap":521007500},{"date":"2024-07-15","current":8.490178,"twenty":-11.330837,"median":5.416906,"eighty":12.760309,"marketCap":536341500},{"date":"2024-08-02","current":8.85152,"twenty":-11.361791,"median":5.389174,"eighty":12.827876,"marketCap":559168250},{"date":"2024-08-09","current":8.857037,"twenty":-11.361791,"median":5.389174,"eighty":12.827876,"marketCap":559516750},{"date":"2024-08-16","current":-21.276829,"twenty":-11.460284,"median":5.295195,"eighty":12.827876,"marketCap":589836250},{"date":"2024-08-23","current":-25.167629,"twenty":-11.629128,"median":5.191971,"eighty":12.827876,"marketCap":697697000},{"date":"2024-08-30","current":-23.124802,"twenty":-11.685409,"median":5.191971,"eighty":12.827876,"marketCap":641065750},{"date":"2024-09-06","current":-22.018532,"twenty":-11.720585,"median":5.191971,"eighty":12.827876,"marketCap":610397750},{"date":"2024-09-13","current":-22.980232,"twenty":-11.828492,"median":4.955967,"eighty":12.827876,"marketCap":637058000},{"date":"2024-09-20","current":-24.457353,"twenty":-11.973851,"median":4.030123,"eighty":12.827876,"marketCap":678006750},{"date":"2024-09-27","current":-25.054487,"twenty":-12.101184,"median":-1.088204,"eighty":12.827876,"marketCap":694560500},{"date":"2024-10-04","current":-27.493309,"twenty":-12.300444,"median":-5.797661,"eighty":12.827876,"marketCap":762169500},{"date":"2024-10-11","current":-29.536136,"twenty":-12.602666,"median":-5.981431,"eighty":12.827876,"marketCap":818800750},{"date":"2024-10-18","current":-33.156654,"twenty":-13.651738,"median":-6.153346,"eighty":12.827876,"marketCap":919168750},{"date":"2024-10-25","current":-33.917214,"twenty":-13.961285,"median":-6.337116,"eighty":12.827876,"marketCap":940253000},{"date":"2024-10-31","current":-34.696631,"twenty":-20.937405,"median":-6.977348,"eighty":12.827876,"marketCap":961860000},{"date":"2024-11-08","current":231.054558,"twenty":-21.588596,"median":-7.224352,"eighty":12.835684,"marketCap":1196400500},{"date":"2024-11-15","current":220.723397,"twenty":-21.588596,"median":-7.224352,"eighty":13.005158,"marketCap":1142905750},{"date":"2024-11-22","current":226.982667,"twenty":-21.588596,"median":-7.224352,"eighty":13.415984,"marketCap":1175316250},{"date":"2024-11-29","current":255.755118,"twenty":-21.588596,"median":-7.224352,"eighty":13.679636,"marketCap":1324300000},{"date":"2024-12-06","current":231.020906,"twenty":-21.588596,"median":-7.224352,"eighty":13.929623,"marketCap":1196226250},{"date":"2024-12-13","current":202.282107,"twenty":-21.588596,"median":-7.224352,"eighty":14.105393,"marketCap":1047416750},{"date":"2024-12-20","current":184.278293,"twenty":-21.588596,"median":-7.224352,"eighty":14.388456,"marketCap":954193000},{"date":"2024-12-27","current":214.363171,"twenty":-21.588596,"median":-7.224352,"eighty":14.667732,"marketCap":1109972500},{"date":"2025-01-03","current":218.06489,"twenty":-21.588596,"median":-7.224352,"eighty":15.003831,"marketCap":1129140000},{"date":"2025-01-10","current":242.193366,"twenty":-21.623795,"median":-7.25992,"eighty":15.445599,"marketCap":1254077250},{"date":"2025-01-17","current":253.298523,"twenty":-21.623795,"median":-7.25992,"eighty":17.971916,"marketCap":1311579750},{"date":"2025-01-24","current":270.797557,"twenty":-21.623795,"median":-7.25992,"eighty":18.250535,"marketCap":1402189750},{"date":"2025-01-31","current":219.478273,"twenty":-21.623795,"median":-7.25992,"eighty":18.950793,"marketCap":1136458500},{"date":"2025-02-07","current":224.357812,"twenty":-21.623795,"median":-7.25992,"eighty":19.834196,"marketCap":1161724750},{"date":"2025-02-14","current":233.847673,"twenty":-21.623795,"median":-7.25992,"eighty":20.370632,"marketCap":1210863250},{"date":"2025-02-21","current":325.162676,"twenty":-21.623795,"median":-7.25992,"eighty":20.60452,"marketCap":1683692335},{"date":"2025-02-28","current":291.433785,"twenty":-21.623795,"median":-7.25992,"eighty":21.555863,"marketCap":1509044138},{"date":"2025-03-07","current":279.929711,"twenty":-21.658995,"median":-7.295488,"eighty":21.769894,"marketCap":1430440822},{"date":"2025-03-14","current":306.916919,"twenty":-21.658995,"median":-7.295488,"eighty":21.989972,"marketCap":1568345457},{"date":"2025-03-21","current":362.620702,"twenty":-21.658995,"median":-7.295488,"eighty":22.081837,"marketCap":1852991785},{"date":"2025-03-28","current":347.056409,"twenty":-21.658995,"median":-7.295488,"eighty":22.332316,"marketCap":1773458252},{"date":"2025-04-04","current":302.047389,"twenty":-21.658995,"median":-7.054413,"eighty":23.159096,"marketCap":1543462159},{"date":"2025-04-11","current":286.028001,"twenty":-21.623795,"median":-6.337116,"eighty":197.341995,"marketCap":1461603084},{"date":"2025-04-17","current":307.872621,"twenty":-21.623795,"median":-6.173106,"eighty":205.142526,"marketCap":1573229095},{"date":"2025-04-25","current":326.850135,"twenty":-21.658995,"median":-5.987359,"eighty":214.228563,"marketCap":1670204192},{"date":"2025-05-02","current":341.094649,"twenty":-21.658995,"median":-5.805565,"eighty":217.795674,"marketCap":1742993654},{"date":"2025-05-09","current":2014.303961,"twenty":-21.658995,"median":-5.477544,"eighty":219.310013,"marketCap":1607414561},{"date":"2025-05-16","current":2340.695807,"twenty":-21.658995,"median":7.384082,"eighty":223.577086,"marketCap":1867875254},{"date":"2025-05-23","current":2275.126016,"twenty":-21.658995,"median":8.277785,"eighty":230.280562,"marketCap":1815550561},{"date":"2025-05-30","current":2160.88887,"twenty":-21.658995,"median":8.85152,"eighty":234.332262,"marketCap":1724389318},{"date":"2025-06-06","current":2095.31908,"twenty":-21.658995,"median":12.255883,"eighty":236.990769,"marketCap":1672064626},{"date":"2025-06-13","current":2129.706792,"twenty":-21.658995,"median":12.779071,"eighty":244.414397,"marketCap":1699506020},{"date":"2025-06-20","current":2068.799742,"twenty":-21.694194,"median":12.843493,"eighty":247.33539,"marketCap":1650902194},{"date":"2025-06-27","current":1967.967976,"twenty":-21.694194,"median":13.054428,"eighty":253.009116,"marketCap":1570438445},{"date":"2025-07-03","current":2107.948456,"twenty":-21.694194,"median":13.420706,"eighty":255.755118,"marketCap":1682142868},{"date":"2025-07-11","current":1973.660129,"twenty":-21.694194,"median":13.801025,"eighty":271.29504,"marketCap":1574980783},{"date":"2025-07-18","current":1762.455484,"twenty":-21.694194,"median":14.001145,"eighty":281.422426,"marketCap":1406439476},{"date":"2025-07-25","current":1694.050397,"twenty":-21.694194,"median":14.226624,"eighty":292.583531,"marketCap":1351852217},{"date":"2025-08-01","current":1786.728256,"twenty":-21.694194,"median":14.441607,"eighty":298.697881,"marketCap":1425809148},{"date":"2025-08-08","current":67.042436,"twenty":-21.694194,"median":14.869709,"eighty":301.428458,"marketCap":1278901501},{"date":"2025-08-15","current":20.602926,"twenty":-21.694194,"median":15.24196,"eighty":301.428458,"marketCap":1358824811},{"date":"2025-08-22","current":20.380109,"twenty":-21.694194,"median":17.881349,"eighty":301.428458,"marketCap":1344129335},{"date":"2025-08-29","current":20.180342,"twenty":-21.694194,"median":18.265026,"eighty":301.428458,"marketCap":1330954080},{"date":"2025-09-05","current":20.806536,"twenty":-21.729394,"median":18.925687,"eighty":302.047389,"marketCap":1372253436},{"date":"2025-09-12","current":19.884532,"twenty":-21.694194,"median":19.67324,"eighty":301.428458,"marketCap":1311444569},{"date":"2025-09-19","current":20.188025,"twenty":-21.694194,"median":19.810304,"eighty":301.428458,"marketCap":1331460821},{"date":"2025-09-26","current":20.891052,"twenty":-21.694194,"median":19.90182,"eighty":301.428458,"marketCap":1377827582},{"date":"2025-10-03","current":21.747747,"twenty":-21.694194,"median":20.009538,"eighty":301.428458,"marketCap":1434329155},{"date":"2025-10-10","current":20.403159,"twenty":-21.694194,"median":20.110528,"eighty":301.428458,"marketCap":1345649557},{"date":"2025-10-17","current":20.483834,"twenty":-21.694194,"median":20.149608,"eighty":301.428458,"marketCap":1350970332},{"date":"2025-10-24","current":22.965559,"twenty":-21.694194,"median":20.328304,"eighty":301.428458,"marketCap":1514647533},{"date":"2025-10-31","current":22.765792,"twenty":-21.694194,"median":20.410843,"eighty":301.428458,"marketCap":1501472279},{"date":"2025-11-07","current":25.443443,"twenty":-21.694194,"median":20.489339,"eighty":301.428458,"marketCap":1678071364},{"date":"2025-11-14","current":28.086518,"twenty":-21.694194,"median":20.63366,"eighty":301.428458,"marketCap":1852390117},{"date":"2025-11-21","current":61.71834,"twenty":-21.694194,"median":20.848794,"eighty":301.428458,"marketCap":1513704008},{"date":"2025-11-28","current":58.691311,"twenty":-21.694194,"median":21.058166,"eighty":301.428458,"marketCap":1439463085},{"date":"2025-12-05","current":61.315425,"twenty":-21.498083,"median":21.426712,"eighty":301.428458,"marketCap":1503822110},{"date":"2025-12-12","current":58.371045,"twenty":-15.571535,"median":21.717022,"eighty":301.428458,"marketCap":1431608243},{"date":"2025-12-19","current":54.341893,"twenty":7.414424,"median":21.765389,"eighty":301.428458,"marketCap":1332789267},{"date":"2025-12-26","current":54.858451,"twenty":8.253511,"median":21.801388,"eighty":301.428458,"marketCap":1345458366},{"date":"2026-01-02","current":50.612345,"twenty":8.743393,"median":21.958249,"eighty":300.809527,"marketCap":1241318369},{"date":"2026-01-09","current":48.680418,"twenty":8.852623,"median":22.024339,"eighty":298.697881,"marketCap":1193935936},{"date":"2026-01-16","current":61.739002,"twenty":12.256273,"median":22.235825,"eighty":298.697881,"marketCap":1514210772},{"date":"2026-01-23","current":61.728671,"twenty":12.754055,"median":22.33496,"eighty":298.697881,"marketCap":1513957390},{"date":"2026-01-30","current":61.687347,"twenty":12.843493,"median":22.765792,"eighty":298.697881,"marketCap":1512943862},{"date":"2026-02-06","current":56.387462,"twenty":12.91182,"median":22.904092,"eighty":297.678465,"marketCap":1382958901},{"date":"2026-02-13","current":61.656353,"twenty":13.098027,"median":23.289953,"eighty":297.678465,"marketCap":1512183716},{"date":"2026-02-20","current":69.115449,"twenty":13.487718,"median":26.451401,"eighty":297.678465,"marketCap":1695125513},{"date":"2026-02-27","current":68.78238,"twenty":13.74732,"median":32.865567,"eighty":297.678465,"marketCap":2072275533},{"date":"2026-03-06","current":68.874779,"twenty":13.74732,"median":50.064793,"eighty":297.678465,"marketCap":2075059353},{"date":"2026-03-13","current":67.193104,"twenty":13.74732,"median":53.15381,"eighty":297.678465,"marketCap":2024393831},{"date":"2026-03-20","current":65.650028,"twenty":13.768802,"median":54.285072,"eighty":296.977455,"marketCap":1977904038},{"date":"2026-03-27","current":67.239304,"twenty":13.768802,"median":55.597128,"eighty":296.977455,"marketCap":2025785741},{"date":"2026-04-02","current":61.14092,"twenty":13.768802,"median":57.027994,"eighty":296.977455,"marketCap":1842053627},{"date":"2026-04-10","current":59.024965,"twenty":13.768802,"median":58.123097,"eighty":296.977455,"marketCap":1778304152},{"date":"2026-04-17","current":64.162392,"twenty":13.768802,"median":58.613827,"eighty":296.977455,"marketCap":1933084538},{"date":"2026-04-24","current":64.365671,"twenty":13.768802,"median":58.976946,"eighty":296.977455,"marketCap":1939208942},{"date":"2026-05-01","current":63.506353,"twenty":13.768802,"median":59.827738,"eighty":296.977455,"marketCap":1913319417},{"date":"2026-05-08","current":55.000941,"twenty":13.768802,"median":60.468269,"eighty":296.977455,"marketCap":1780875479},{"date":"2026-05-15","current":58.03601,"twenty":13.768802,"median":60.468269,"eighty":296.977455,"marketCap":1879147957},{"date":"2026-05-22","current":65.413031,"twenty":13.879719,"median":61.086611,"eighty":296.977455,"marketCap":2118008542},{"date":"2026-05-29","current":64.690805,"twenty":14.083138,"median":61.656353,"eighty":297.678465,"marketCap":2094623589},{"date":"2026-06-05","current":63.856806,"twenty":14.345513,"median":61.702844,"eighty":296.977455,"marketCap":2067619537},{"date":"2026-06-12","current":57.975824,"twenty":14.45874,"median":61.702844,"eighty":296.977455,"marketCap":1877199211},{"date":"2026-06-18","current":54.596839,"twenty":14.82393,"median":61.702844,"eighty":296.977455,"marketCap":1767791041},{"date":"2026-06-26","current":52.369976,"twenty":15.399872,"median":61.71834,"eighty":297.678465,"marketCap":1695687438},{"date":"2026-07-02","current":62.163015,"twenty":19.669398,"median":61.739002,"eighty":297.678465,"marketCap":2012776256},{"date":"2026-07-10","current":67.399153,"twenty":19.807699,"median":62.332877,"eighty":297.678465,"marketCap":2182317161},{"date":"2026-07-17","current":66.229834,"twenty":19.934474,"median":62.683996,"eighty":297.678465,"marketCap":2144455809},{"date":"2026-07-24","current":65.963299,"twenty":20.049725,"median":62.92823,"eighty":297.678465,"marketCap":2135825648},{"date":"2026-07-31","current":65.774144,"twenty":20.186488,"median":63.464774,"eighty":297.933319,"marketCap":2129701018},{"date":"2026-08-07","current":60.22694,"twenty":20.270237,"median":63.464774,"eighty":295.575435,"marketCap":2238274011},{"date":"2026-08-14","current":57.536583,"twenty":20.350912,"median":63.349529,"eighty":293.823102,"marketCap":2138289555},{"date":"2026-08-21","current":66.51712,"twenty":20.393939,"median":63.127515,"eighty":293.212299,"marketCap":2472042242},{"date":"2026-08-28","current":68.190939,"twenty":20.407769,"median":63.409714,"eighty":292.906898,"marketCap":2534248062},{"date":"2026-08-31","current":66.448333,"twenty":20.409306,"median":63.430314,"eighty":292.888933,"marketCap":2469485838}],"updateTime":1788322314701},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LB\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2626902112","title":"LB Pharmaceuticals Initiated at Buy by Craig-Hallum","url":"https://stock-news.laohu8.com/highlight/detail?id=2626902112","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626902112?lang=en_us&edition=fundamental","pubTime":"2026-04-11 02:04","pubTimestamp":1775844240,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LBRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 10, 2026 14:04 ET (18:04 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4233","BK4007","LB","BK4213","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626411111","title":"Lixte Biotech Holdings (NASDAQ: LIXT) Advances Precision Oncology Strategy with LB-100, Expands Clinical and Strategic Partnerships","url":"https://stock-news.laohu8.com/highlight/detail?id=2626411111","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626411111?lang=en_us&edition=fundamental","pubTime":"2026-04-11 00:00","pubTimestamp":1775836809,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, April 10th, 2026, FinanceWire LIXT is advancing its lead candidate LB-100, a first-in-class therapy designed to enhan...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/lixte-biotech-holdings-nasdaq-lixt-advances-precision-oncology-strategy-with-lb-100-expands-clinical-and-strategic-partnerships?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/lixte-biotech-holdings-nasdaq-lixt-advances-precision-oncology-strategy-with-lb-100-expands-clinical-and-strategic-partnerships?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TQQY","GPIQ","IYW","LB","QDTE","ONEQ","BK4233","NVIW.SI",".IXIC","XBI","BK4585","BK4581","QQQJ","BK4588","MNQmain","BK4139","QQQ","LIXT","FTEC","QYLG","QLD","NQmain","TQQQ","QID","QQQE","QQQY","PSQ","BK4213","JEPQ","NDX","QQQM","QQQA","SQQQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626419263","title":"LB Pharmaceuticals initiated with a Buy at Craig-Hallum","url":"https://stock-news.laohu8.com/highlight/detail?id=2626419263","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626419263?lang=en_us&edition=fundamental","pubTime":"2026-04-10 19:33","pubTimestamp":1775820835,"startTime":"0","endTime":"0","summary":"Craig-Hallum initiated coverage of LB Pharmaceuticals (LBRX) with a Buy rating and $36 price target Published first on TheFly – the ultimate source...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-initiated-with-a-buy-at-craig-hallum-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-initiated-with-a-buy-at-craig-hallum-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LBRX","BK4233","BK4213","BK4007","LB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626515398","title":"LB Pharmaceuticals Announces Presentation at 25th Annual Needham Virtual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2626515398","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626515398?lang=en_us&edition=fundamental","pubTime":"2026-04-10 04:05","pubTimestamp":1775765100,"startTime":"0","endTime":"0","summary":"NEW YORK, April  09, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schiz","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/09/3271401/0/en/LB-Pharmaceuticals-Announces-Presentation-at-25th-Annual-Needham-Virtual-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4233","XLV","XBI","BK4588","BK4213","BK4585","HCSG","LB","LBRX","BK4137","BK4581","LU0128526141.USD","LU0029874061.USD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625601308","title":"LB Pharmaceuticals files to sell 4.78M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2625601308","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625601308?lang=en_us&edition=fundamental","pubTime":"2026-04-07 04:13","pubTimestamp":1775506382,"startTime":"0","endTime":"0","summary":"16:06 EDT LB Pharmaceuticals (LBRX) files to sell 4.78M shares of common stock for holders Published first on TheFly – the ultimate source for real...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-files-to-sell-4-78m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-files-to-sell-4-78m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LBRX","LB","BK4213","BK4007","BK4233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624995509","title":"LandBridge signs lease development deal with PowerBridge for 2 GW West Texas data center campus","url":"https://stock-news.laohu8.com/highlight/detail?id=2624995509","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624995509?lang=en_us&edition=fundamental","pubTime":"2026-04-02 20:30","pubTimestamp":1775133050,"startTime":"0","endTime":"0","summary":"LandBridge signed lease development agreement with PowerBridge for option to lease up to 3,400 acres in Reeves County, Texas for a giga-scale data center campus.Alpha Digital Campus targets up to 2 GW of initial co-located power generation near Waha natural gas hub.PowerBridge secured rights to advance site development activities, pursue entitlements, then lease property on long-term basis for digital infrastructure.Large-scale power generation is expected to follow in 2028.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nNDL9nzJqW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LB","BK4213","BK4233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624050999","title":"Landbridge Announces Agreement With Powerbridge for the Development of a 2 Gw Powered Data Center Campus","url":"https://stock-news.laohu8.com/highlight/detail?id=2624050999","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624050999?lang=en_us&edition=fundamental","pubTime":"2026-04-02 20:30","pubTimestamp":1775133000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nTUA7CT1SB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4213","LB","BK4233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624167590","title":"LIXTE Biotechnology (NASDAQ: LIXT) Strengthens Oncology Pipeline Through Expanded LB-100 Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2624167590","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624167590?lang=en_us&edition=fundamental","pubTime":"2026-04-01 19:19","pubTimestamp":1775042368,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, March 31st, 2026, FinanceWire Ovarian clear cell carcinoma and metastatic colon cancer remain among the most challeng...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/lixte-biotechnology-nasdaq-lixt-strengthens-oncology-pipeline-through-expanded-lb-100-clinical-trials-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/lixte-biotechnology-nasdaq-lixt-strengthens-oncology-pipeline-through-expanded-lb-100-clinical-trials-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QQQJ","MNQmain","QLD","NVIW.SI","QID","TQQQ","QQQ","QQQM","SQQQ","LIXT","IYW","BK4213","GPIQ","FTEC","QQQE","PSQ","NQmain","NDX","BK4139","BK4233","QDTE","JEPQ","LB",".IXIC","QQQY","QYLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623027943","title":"LB Aluminium Malaysia 3rd-Quarter 2026 Earnings Summary Table","url":"https://stock-news.laohu8.com/highlight/detail?id=2623027943","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623027943?lang=en_us&edition=fundamental","pubTime":"2026-03-31 17:26","pubTimestamp":1774949160,"startTime":"0","endTime":"0","summary":"Figures Are In Ringgit (MYR).Revenue                     270,171,000        253,683,000. PreTax Profit                44,412,000         29,505,000. Net Profit                   19,952,000         12,634,000. Earnings Per Share             4.59 Sen           2.91 Sen. Dividend                       0.00 Sen           0.00 Sen. Revenue                     811,465,000        813,634,000. PreTax Profit               121,911,000         63,783,000. Net Profit                   53,584,000         29,138,000. Earnings Per Share            12.32 Sen           6.70 Sen. Dividend                       0.00 Sen           0.00 Sen. Copyright (c) 2026 Dow Jones & Company, Inc.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622104876","title":"Lixte Biotech (NASDAQ: LIXT) Advances Precision Oncology with LB-100, Strengthens Position Through Liora Technologies Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2622104876","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622104876?lang=en_us&edition=fundamental","pubTime":"2026-03-28 00:00","pubTimestamp":1774627211,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, March 27th, 2026, FinanceWire LIXT is developing LB-100, a first-in-class therapy designed to enhance the effectivene...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/lixte-biotech-nasdaq-lixt-advances-precision-oncology-with-lb-100-strengthens-position-through-liora-technologies-partnership?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/lixte-biotech-nasdaq-lixt-advances-precision-oncology-with-lb-100-strengthens-position-through-liora-technologies-partnership?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QQQJ","MNQmain","QLD","NVIW.SI","QID","TQQQ","SQQQ","LIXT","IYW","GPIQ","FTEC","BK4213","QQQE","BK4588","PSQ","NQmain","BK4139","BK4233","QDTE","BK4585","JEPQ","XBI","LB",".IXIC","QQQY","BK4581","QYLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622089952","title":"LB Pharmaceuticals Q4 EPS $(0.45) Beats $(0.63) Estimate.","url":"https://stock-news.laohu8.com/highlight/detail?id=2622089952","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622089952?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:30","pubTimestamp":1774557043,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals (NASDAQ:LBRX) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.63) by 28.57 percent. This is a 96.81 percent increase over losses of $(14.12) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51496123/lb-pharmaceuticals-q4-eps-0-45-beats-0-63-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LBRX","LB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622789989","title":"LB Pharmaceuticals reports Q4 EPS (45c), consensus (32c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2622789989","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622789989?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:12","pubTimestamp":1774555927,"startTime":"0","endTime":"0","summary":"“2025 was a transformative year for LB. It began with the presentation of positive Phase 2 trial results of LB-102 in acute schizophrenia that supp...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-reports-q4-eps-45c-consensus-32c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-reports-q4-eps-45c-consensus-32c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LB","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622989619","title":"Press Release: LB Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2622989619","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622989619?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:05","pubTimestamp":1774555500,"startTime":"0","endTime":"0","summary":"Reported positive results from potentially registrational Phase 2 trial of. Advanced LB-102 into late-stage development in multiple indications with initiation of. a pivotal Phase 3 NOVA-2 trial in schizophrenia, and Phase 2 ILLUMINATE-1 trial. Announced pipeline expansion with plans to initiate a Phase 2 trial of LB-102 for the. adjunctive treatment of major depressive disorder  in early 2027. Cash, cash equivalents, and investments of $295.2 million as of December 31, 2025,and proceeds from recent $100 million private placement, expected to provide cash runway into Q2 2029. The Company is building a pipeline that leverages the broad therapeutic potential of LB-102, which has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States.-- Reported positive results in January 2025 from a robust 359 patient Phase. 2 trial  of LB-102 in acute schizophrenia. The trial met the. baseline in the Positive and Negative Syndrome Scale  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","ABVC","LB","BK4213","LBRX","BK4233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622739280","title":"LB Pharmaceuticals Initiates Pivotal Phase 3 Trial (NOVA-2) for LB-102 in Patients with Schizophrenia","url":"https://stock-news.laohu8.com/highlight/detail?id=2622739280","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622739280?lang=en_us&edition=fundamental","pubTime":"2026-03-25 20:00","pubTimestamp":1774440000,"startTime":"0","endTime":"0","summary":"LB-102 has potential to be the first benzamide approved for schizophrenia in the U.S. NOVA-2 trial to enroll approximately 460 patients Primary endpoint to evaluate change in PANSS total score at week","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/25/3262125/0/en/LB-Pharmaceuticals-Initiates-Pivotal-Phase-3-Trial-NOVA-2-for-LB-102-in-Patients-with-Schizophrenia.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4233","PSP","LBRX","BK4007","LB","BK4213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621329062","title":"VisionWave Secures Exclusive Pathway to Offshore Energy Blocks LB-4 & LB-5 In Liberia","url":"https://stock-news.laohu8.com/highlight/detail?id=2621329062","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621329062?lang=en_us&edition=fundamental","pubTime":"2026-03-24 20:00","pubTimestamp":1774353600,"startTime":"0","endTime":"0","summary":"Goal of Expanding Into Global Exploration Market Company to introduce proprietary RF sensing technologies alongside conventional offshore discovery methods in Liberia Basin WEST HOLLYWOOD, Calif., Mar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/24/3261155/0/en/VisionWave-Secures-Exclusive-Pathway-to-Offshore-Energy-Blocks-LB-4-LB-5-In-Liberia.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU1880398554.USD","BK4213","BK4211","LU1880398471.USD","RF","LU1883839398.USD","LB","BK4588","BK4233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621670562","title":"Vaxcyte Completes Enrollment of OPUS-1 and OPUS-2 Phase 3 Trials Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2621670562","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621670562?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:30","pubTimestamp":1774269000,"startTime":"0","endTime":"0","summary":"OPUS-1 Phase 3 Study Designed to Establish a New Standard for Adult Pneumococcal Conjugate Vaccines (PCVs) Through Head-to-Head Safety, Tolerability and Immunogenicity Comparisons of VAX-31 with Capva","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/23/3260381/0/en/Vaxcyte-Completes-Enrollment-of-OPUS-1-and-OPUS-2-Phase-3-Trials-Evaluating-VAX-31-for-the-Prevention-of-Invasive-Pneumococcal-Disease-and-Pneumonia-in-Adults.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","IE0009354923.USD","IE00BSNM7G36.USD","IE0002270589.USD","BK4213","BK4585","LU0289739699.SGD","OPUS","BK4196","LB","LU1169589451.USD","BK4233","LU1261432733.SGD","LU0053671581.USD","LU1169590202.USD","PCVX","BK4139","BK4588","LU0058720904.USD","LU1059921491.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","CI","LU0868494617.USD","PD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621708363","title":"Analysts Offer Insights on Energy Companies: Precision Drilling (PDS) and LandBridge Company LLC Class A (LB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2621708363","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621708363?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:30","pubTimestamp":1774265453,"startTime":"0","endTime":"0","summary":"Companies in the Energy sector have received a lot of coverage today as analysts weigh in on Precision Drilling (PDS) and LandBridge Company LLC Cl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-energy-companies-precision-drilling-pds-and-landbridge-company-llc-class-a-lb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-energy-companies-precision-drilling-pds-and-landbridge-company-llc-class-a-lb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LB","BK4213","BK4233","PDS","BK4092"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620331457","title":"Analysts Offer Insights on Energy Companies: Phillips 66 (PSX) and LandBridge Company LLC Class A (LB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2620331457","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620331457?lang=en_us&edition=fundamental","pubTime":"2026-03-20 19:50","pubTimestamp":1774007442,"startTime":"0","endTime":"0","summary":"Companies in the Energy sector have received a lot of coverage today as analysts weigh in on Phillips 66 (PSX) and LandBridge Company LLC Class A (...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-energy-companies-phillips-66-psx-and-landbridge-company-llc-class-a-lb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-energy-companies-phillips-66-psx-and-landbridge-company-llc-class-a-lb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4138","BK4233","LU0130517989.USD","IE00BSNM7G36.USD","LB","BK4213","LU0980610538.SGD","PSX","LU1201861249.SGD","BK4585","BK4588","LU0477156953.USD","LU0648001328.SGD","LU0130102774.USD","IE00B3T34201.USD","LU0300736492.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620788007","title":"LandBridge Company LLC Class A (LB) Receives a Rating Update from a Top Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2620788007","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620788007?lang=en_us&edition=fundamental","pubTime":"2026-03-20 15:19","pubTimestamp":1773991160,"startTime":"0","endTime":"0","summary":"Barclays analyst Theresa Chen maintained a Hold rating on LandBridge Company LLC Class A today and set a price target of $75.00. Chen covers the En...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/landbridge-company-llc-class-a-lb-receives-a-rating-update-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/landbridge-company-llc-class-a-lb-receives-a-rating-update-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620717832","title":"CervoMed Highlights RewinD-LB Phase 2b Biomarker-Driven Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2620717832","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620717832?lang=en_us&edition=fundamental","pubTime":"2026-03-20 04:59","pubTimestamp":1773953977,"startTime":"0","endTime":"0","summary":"CervoMed ( ($CRVO) ) has shared an update. On March 19, 2026, CervoMed reported new analyses from its Phase 2b RewinD-LB trial showing that DLB pat...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cervomed-highlights-rewind-lb-phase-2b-biomarker-driven-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cervomed-highlights-rewind-lb-phase-2b-biomarker-driven-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4213","LB","BK4233","CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":5,"totalSize":111,"code":"91000000","status":"200"}]}}